Comparing COVID-19 disease severity in patients with rheumatic and inflammatory diseases between the first and the subsequent waves

Elodie Drumez; Christophe Richez; Louis Bebear; Muriel Herasse; René-Marc Flipo; Hubert Marotte; Sophie Georgin-Lavialle; Raphaèle Seror; Edouard Pertuiset; Jérôme Avouac; Pascal Chazerain; Nicolas Roux; Thao Pham; Emmanuelle Dernis; Yurdagul Uzunhan; Amélie Servettaz; Soumaya El Mahou; Patrice Cacoub; Mohamed Hamidou; Bruno Fautrel; Thierry Thomas; Eric Hachulla; Consortium; contributors

doi:10.1016/j.jbspin.2023.105605

Comparing COVID-19 disease severity in patients with rheumatic and inflammatory diseases between the first and the subsequent waves

Joint Bone Spine. 2023 Sep;90(5):105605. doi: 10.1016/j.jbspin.2023.105605. Epub 2023 Jul 1.

Authors

Elodie Drumez¹, Christophe Richez², Louis Bebear³, Muriel Herasse⁴, René-Marc Flipo⁵, Hubert Marotte⁶, Sophie Georgin-Lavialle⁷, Raphaèle Seror⁸, Edouard Pertuiset⁹, Jérôme Avouac¹⁰, Pascal Chazerain¹¹, Nicolas Roux¹², Thao Pham¹³, Emmanuelle Dernis¹⁴, Yurdagul Uzunhan¹⁵, Amélie Servettaz¹⁶, Soumaya El Mahou¹⁷, Patrice Cacoub¹⁸, Mohamed Hamidou¹⁹, Bruno Fautrel²⁰, Thierry Thomas²¹, Eric Hachulla²²; Consortium; contributors

Affiliations

¹ Department of Biostatistics, CHU of Lille, Lille, Hauts-de-France, France.
² CNRS, ImmunoConcEpT, UMR 5164, Department of Rheumatology, University of Bordeaux, CHU of Bordeaux, 33000 Bordeaux, France. Electronic address: [email protected].
³ Department of Rheumatology, CHU of Bordeaux, 33000 Bordeaux, France.
⁴ Filière des maladies auto-immunes et auto-inflammatoires rares, hôpital Huriez, centre hospitalier universitaire de Lille, Lille, France.
⁵ Service de rhumatologie, université de Lille, CHU de Lille, Lille, France.
⁶ Inserm, SAINBIOSE U1059, service de rhumatologie, Mines Saint-Étienne, université Jean-Monnet Saint-Étienne, CHU de Saint-Étienne, 42023 Saint-Étienne, France.
⁷ Internal Medicine Department, Tenon Hospital, Sorbonne University, AP-HP, 4, rue de la Chine, 75020 Paris, France; National Reference Center for Autoinflammatory Diseases and AA Amyloidosis (CEREMAIA), Tenon Hospital, Paris, France.
⁸ Inserm UMR 1184, service de rhumatologie, Centre de référence des maladies auto-immunes systémiques rares, hôpital Bicêtre, université Paris-Saclay, Assistance publique-Hôpitaux de Paris (AP-HP), Le Kremlin-Bicêtre, France.
⁹ Service de rhumatologie, centre hospitalier René-Dubos, Pontoise, France.
¹⁰ Service de rhumatologie, hôpital Cochin, centre université de Paris Cité, université de Paris, Assistance publique-Hôpitaux de Paris, Paris, France.
¹¹ Internal Medicine and Rheumatology Department, Groupe Hospitalier Diaconesses Croix Saint-Simon, 75020 Paris, France.
¹² Rheumatology department, Hôpitaux Privés de Metz - Hôpital Robert-Schuman, Metz, France.
¹³ Department of Rheumatology, Sainte-Marguerite Hospital, Aix-Marseille University, AP-HM, Marseille, France.
¹⁴ Department of Rheumatology and Clinical Immunology, General Hospital, Le Mans, France.
¹⁵ Inserm UMR 1272, Department of Respiratory Medicine, Reference Center for Rare Pulmonary Diseases, Hôpital Avicenne, Université Sorbonne Paris Nord, AP-HP, Bobigny, France.
¹⁶ Service de médecine interne, maladies infectieuses et immunologie clinique, hôpital Robert-Debré, CHU de Reims, Reims, France.
¹⁷ Service de rhumatologie, centre hospitalier de Dron, 59200 Tourcoing, France.
¹⁸ UMR 959, Department of Internal Medicine and Clinical Immunology, Centre de Référence des Maladies Auto-Immunes Systémiques Rares, Pitié-Salpêtrière Hospital, Sorbonne Université, 75013 Paris, France.
¹⁹ Service de médecine interne, PHU3, centre hospitalier universitaire de Nantes - Hôtel-Dieu, 1, place Alexis-Ricordeau, 44093 Nantes, France.
²⁰ Inserm UMRS 1136, département de rhumatologie, hôpital Pitié-Salpêtrière, Institut Pierre-Louis d'épidémiologie et de santé publique, Sorbonne université, AP-HP, 75013 Paris, France.
²¹ Inserm, SAINBIOSE U1059, service de rhumatologie, université Jean-Monnet Saint-Étienne, CHU de Saint-Étienne, 42023 Saint-Étienne, France.
²² Department of Internal Medicine and Clinical immunology, Referral Centre for Rare Systemic Auto-immune Diseases North and North-West of France, Lille University School of Medicine, Lille, France.

PMID: 37399939
DOI: 10.1016/j.jbspin.2023.105605

No abstract available

Keywords: COVID-19 update; Connective tissue diseases; Rheumatic disorders; Rituximab; Systemic auto-inflammatory diseases; Vasculitis.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Arthritis, Rheumatoid*
COVID-19*
Humans
Patient Acuity
Rheumatic Diseases* / epidemiology